BACE1 and Alzheimer disease: Further, plasma exosomal BACE1-AS, 51A, BC200, and BACE1 expression were quantified, and results showed that solely BACE1-AS was dysregulated when comparing AD specimens to healthy controls (210), indicating BACE1-AS as a potential marker in combination with cortical thickness (211).